glp-1 ibd More encouraging news about medications. New research presented at ASCO found that patients with inflammatory bowel disease (IBD) who used GLP- 1 receptor agonists had a 51% lower odds of developing colorectal Ozempic and Crohn's Disease: Could

The protocol doesnt require adrenal testing

This is an important finding because it suggests that the GLP-1 system does play a direct role in anxiety regulation, not just an indirect one

For example, in one study, GLP-1/GIP weight loss program showed extremely similar results to its Ozempic counterpart by helping obese participants lose 20% or more of their starting weight

Even if these approaches are successful in many cases, there is still a subset (3%5% of patients) that progress to therapeutically refractive disease, constituting the so-called TC-related deaths due to the lack of effective treatment. In this view, some efforts are ongoing to identify personalized therapy for refractory patients and drug repositioning represents one of the potential alternatives (Xu et al., 2019)

Tirzepatide uses a different titration schedule and different target doses